Immunovant (IMVT) Total Liabilities (2018 - 2026)
Immunovant (IMVT) recorded Total Liabilities of $117.1 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 121.4% from $52.9 million a year earlier and up 12.1% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Total Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant reported Total Liabilities of $104.42 million, up 51.8% from FY2025.
- Annual Total Liabilities has increased for three straight fiscal years, with a five-year compound annual growth rate of 37.8% (FY2021 to FY2026).
- Across earlier fiscal years, Total Liabilities came in at $68.78 million in FY2025 (+41.5%), $48.61 million in FY2024 (+12.1%), $43.34 million in FY2023 (-5.2%) and $45.74 million in FY2022 (+117.7%).
- The fiscal Q1 2027 figure is the highest quarterly Total Liabilities since fiscal Q2 2020.
- On a year-over-year basis, Total Liabilities rose in six of the last eight quarters, with growth averaging 50.3%.
- Peak year-over-year performance for Total Liabilities in the last five years was growth of 131.7% in fiscal Q1 2024, against a decline of 22.8% in fiscal Q3 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $104.42 million (Q4 2026), $66.26 million (Q3 2026) and $63.25 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Immunovant | 6.91 Bn | 6.91 Bn | - | 117.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117.10 Mn |
| Mar 31, 2026 | 104.42 Mn |
| Dec 31, 2025 | 66.26 Mn |
| Sep 30, 2025 | 63.25 Mn |
| Jun 30, 2025 | 52.90 Mn |
| Mar 31, 2025 | 68.78 Mn |
| Dec 31, 2024 | 68.32 Mn |
| Sep 30, 2024 | 66.65 Mn |
| Jun 30, 2024 | 45.02 Mn |
| Mar 31, 2024 | 48.61 Mn |
| Dec 31, 2023 | 32.10 Mn |
| Sep 30, 2023 | 40.26 Mn |
| Jun 30, 2023 | 51.36 Mn |
| Mar 31, 2023 | 43.34 Mn |
| Dec 31, 2022 | 41.57 Mn |
| Sep 30, 2022 | 32.40 Mn |
| Jun 30, 2022 | 22.16 Mn |
| Mar 31, 2022 | 45.74 Mn |
| Dec 31, 2021 | 38.03 Mn |
| Sep 30, 2021 | 30.34 Mn |
API Access
Immunovant Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();